---

title: "How pandemics reshape our brain: Common links and targets between long-haul COVID-19, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), oxidative stress, and neurodegeneration."
tags:
- âž• 2025-12-25
- ðŸ§ª Biomarker
created: '2025-05-29'
published: '2025-05-29'

---


<details>
<summary>Herman (2025)</summary>

- **Authors:** Dr. Mary E. Herman.
- **Institutes:** Independent Health Researcher and Educator: Building Global Research Competency, Antigua Guatemala.
- **Publisher:** Neuroprotection (John Wiley & Sons Ltd on behalf of Chinese Medical Association).
- **Link:** [DOI](https://doi.org/10.1002/nep3.70007)

</details>


## Summary

This study highlights that the brain fog, cognitive issues, and physical symptoms experienced by ME/CFS and Long COVID patients are likely driven by measurable biological changes, particularly high levels of cellular oxidative stress and an overactive immune system. By linking these conditions to the long-term effects of pandemics, the research advocates for treating ME/CFS as a serious neurological disorder rather than just a state of fatigue. This shift in perspective is crucial for moving toward future diagnostics and treatments that focus on protecting the brain from the chronic inflammation seen after viral infections.

## What was researched?

This research highlight explored the shared biological mechanisms between long-haul COVID-19 and ME/CFS, specifically focusing on how both conditions involve multisystem metabolic, immune, and inflammatory dysregulation. The author examined the role of oxidative stress in the central nervous system and proposed that ME/CFS serves as a critical model for understanding how the brain is reshaped following a pandemic.

## Why was it researched?

Despite millions of people suffering from fatiguing syndromes, these conditions have historically been underserved and neglected in both clinical practice and basic research. The massive surge in Long COVID casesâ€”approximately half of which meet the diagnostic criteria for ME/CFSâ€”has created an urgent need to bridge the gap between neurobiology and the understanding of neurodegenerative processes in these illnesses.

## How was it researched?

This was a literature-based review and conceptual analysis that synthesized findings from recent neurobiological studies, historical pandemic data, and clinical observations. The author analyzed the overlap in symptoms and pathophysiology between Long COVID and ME/CFS, specifically looking at cellular oxidative stress, the failure of immune "brakes," and historical evidence of autoimmune propensity following major viral outbreaks.

## What has been found?

The paper identifies oxidative stress as a central feature of ME/CFS and Long COVID, suggesting that it contributes to long-term central nervous system malfunction. It highlights that viral infections can act as "provocateurs" that permanently alter immune system activity, potentially leading to the production of autoantibodies against neurotransmitters and steroid hormones. Furthermore, the study notes that the multisystem presentation of Long COVID is strikingly similar to ME/CFS, indicating that both conditions may involve chronic neuroinflammation and potential neurodegenerative aspects if left unaddressed.

## Discussion

The author argues that current Long COVID research often fails to build upon decades of existing ME/CFS knowledge, which can lead to misguided conclusions. There is a critique of the medical community's reluctance to classify ME/CFS as a neurodegenerative or neurological condition despite evidence of declining neurological health and debilitating symptoms in patients.

## Conclusion & Future Work

The author concludes that ME/CFS and Long COVID represent a unified paradigm for studying the impact of sustained oxidative stress on the human brain and body. Future research must prioritize finding neuroprotective strategies and better diagnostic markers to prevent the long-term cognitive and neurological decline associated with these post-viral syndromes.
